RecruitingNCT07482098

Gastric Ultrasound After Clear Fluid Intake in Diabetic and Non-Diabetic Pregnant Women

Effect of Preoperative Clear Fluid Intake on Gastric Volume in Diabetic and Non-Diabetic Pregnant Women Assessed by Gastric Ultrasonography


Sponsor

Ankara City Hospital Bilkent

Enrollment

70 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Pulmonary aspiration of gastric contents during anesthesia is a serious perioperative complication associated with significant morbidity and mortality. Pregnant patients are at increased risk of aspiration due to physiological changes such as delayed gastric emptying and increased intra-abdominal pressure. In addition, diabetes may impair gastric motility because of autonomic neuropathy, potentially leading to gastroparesis and increased gastric residual volume. Current fasting guidelines allow the intake of clear fluids up to two hours before anesthesia. However, the effect of preoperative oral clear fluid intake on gastric volume in diabetic pregnant patients remains unclear. This prospective observational study aims to compare gastric volume measured by gastric ultrasonography in diabetic and non-diabetic pregnant women undergoing elective cesarean delivery. All participants will receive 200 ml of water two hours before surgery. Gastric ultrasonography will be performed before fluid intake and two hours after intake to evaluate gastric volume and gastric content. The results of this study may help improve the assessment of aspiration risk and guide perioperative fasting recommendations in pregnant patients, particularly those with diabetes.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Inclusion Criteria5

  • Pregnant women aged 18-40 years
  • Scheduled for elective cesarean section under spinal anesthesia
  • Singleton pregnancy
  • ASA physical status II
  • Patients who provide written informed consent

Exclusion Criteria7

  • Refusal to participate in the study
  • Contraindication to spinal anesthesia
  • Known allergy to study medications
  • Multiple pregnancy
  • Severe systemic disease (ASA III or higher)
  • Pre-existing neurological disease
  • Infection at the spinal puncture site

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Ankara Bilkent City Hospital

Ankara, Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07482098


Related Trials